Targeting TAZ-TEAD pathway in hepatocellular carcinoma with pan-TEAD inhibition

被引：0
|
作者：
Saito, Yoshinobu [1 ]
Hikita, Hayato [1 ]
Kodama, Takahiro [1 ]
Schwabe, Robert [1 ]
Takehara, Tetsuo [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Gastroenterol & Hepatol, Osaka, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-3017
引用
收藏
页码：1362 / 1362
页数：1
相关论文
共 50 条
  • [21] INHIBITION OF YAP/TAZ-TEAD DEPENDENT TRANSCRIPTION UNDERLIES THE ANTI-MITOGENIC EFFECTS OF CAMP IN VSMC
    Kimura, T. E.
    Duggirala, A.
    Newby, G. N.
    Newby, A. C.
    Bond, M.
    ATHEROSCLEROSIS, 2016, 244 : E7 - E8
  • [22] Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
    Pobbati, Ajaybabu V.
    Rubin, Brian P.
    MOLECULES, 2020, 25 (24):
  • [23] Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)
    Zagiel, Benjamin
    Melnyk, Patricia
    Cotelle, Philippe
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32 (08) : 899 - 912
  • [24] TARGETING OF THE YAP/TAZ-TEAD AXIS DIMINISHES VIABILITY AND DIFFERENTIATION POTENTIAL IN PEDIATRIC HIGH-GRADE GLIOMA
    Macias, Jorge Luis Jimenez
    Oh, Se-Yeong
    Hu, Zhengang
    Yin, Kevin
    Sele, Nisan
    Boon, Nikki
    Sing, Anson
    Sloan, Steven A.
    Read, Renee D.
    NEURO-ONCOLOGY, 2024, 26
  • [25] Discovery of potent and selective pan-TEAD autopalmitoylation inhibitors for the treatment of Hippo-pathway altered cancers
    Gordon, Jacob A.
    Dubauskaite, Jolanta
    DuPont, Michelle
    Guan, Nin
    Holdgate, Geoff
    Mlynarski, Scott
    Umbreit, Neil
    Sanchez, Danielle
    Srivastava, Abhishek
    Suski, Janek
    Su, Nancy
    Richards, Ryan
    Cosulich, Sabina
    Reimer, Corinne
    Brownell, James
    CANCER RESEARCH, 2024, 84 (06)
  • [26] The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment
    Santucci, Matteo
    Vignudelli, Tatiana
    Ferrari, Stefania
    Mor, Marco
    Scalvini, Laura
    Bolognesi, Maria Laura
    Uliassi, Elisa
    Costi, Maria Paola
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (12) : 4857 - 4873
  • [27] Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer Cells
    El Yousfi, Younes
    Mora-Molina, Rocio
    Lopez-Rivas, Abelardo
    Yerbes, Rosario
    CELLS, 2023, 12 (19)
  • [28] BBT-4437, a novel, brain-penetrable, reversible pan-TEAD inhibitor targeting the Hippo signaling pathway in solid tumors
    Revollo, Leila
    Brenneman, Jehrod
    Paudyal, Shared
    Nguyen, Toan
    Lee, Yong-Hee
    Jin, Taiguang Jimmy
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [29] A YAP/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth
    Yu Ting Ong
    Jorge Andrade
    Max Armbruster
    Chenyue Shi
    Marco Castro
    Ana S. H. Costa
    Toshiya Sugino
    Guy Eelen
    Barbara Zimmermann
    Kerstin Wilhelm
    Joseph Lim
    Shuichi Watanabe
    Stefan Guenther
    Andre Schneider
    Francesca Zanconato
    Manuel Kaulich
    Duojia Pan
    Thomas Braun
    Holger Gerhardt
    Alejo Efeyan
    Peter Carmeliet
    Stefano Piccolo
    Ana Rita Grosso
    Michael Potente
    Nature Metabolism, 2022, 4 : 672 - 682
  • [30] Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ-TEAD Biosensors
    Nouri, Kazem
    Azad, Taha
    Ling, Min
    van Rensburg, Helena J. Janse
    Pipchuk, Alexander
    Shen, He
    Hao, Yawei
    Zhang, Jianmin
    Yang, Xiaolong
    CANCERS, 2019, 11 (10)
12345